Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RelieVRx

K-Number: K243417 · 2024-12-04

ApplicantAppliedvr
Decision Date2024-12-04
Product CodeQRA
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

RelieVRx is the device name listed in this FDA 510(k) record. The listed applicant is Appliedvr. It received FDA 510(k) clearance on 2024-12-04 under 510(k) number K243417. The device is classified under product code QRA. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RelieVRx?

RelieVRx is a medical device that received FDA 510(k) clearance on 2024-12-04. The listed applicant is Appliedvr. The 510(k) number is K243417.

When did RelieVRx receive FDA 510(k) clearance?

RelieVRx received FDA 510(k) clearance on 2024-12-04, under 510(k) number K243417.

Who is the listed applicant for RelieVRx?

The FDA 510(k) record lists Appliedvr as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RelieVRx?

The FDA product code for RelieVRx is QRA.

Other records listing Appliedvr as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: QRA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.